CASC2: An emerging tumour ‐suppressing long noncoding RNA in human cancers and melanoma

AbstractDeregulation of long noncoding RNAs (lncRNAs) has been implicated in tumourigenesis. Cancer Susceptibility Candidate 2 (CASC2) is a lncRNA downregulated in multiple cancer types, including endometrial, lung, gastric and colorectal cancers. CASC2 functions as a tumour ‐suppressive lncRNA though multiple mechanisms, such as sequestration of oncogenic microRNAs and repression of Wnt/β‐catenin signalling. Pertinent to clinical practice, the use of CASC2 as a prognostic marker has been demonstrated in sporadic studies. These findings suggested that CASC2 might p lay an important role in human cancers and melanoma. More efforts are warranted to examine the function role of CASC2 in other cancer types. Further validation is also needed to promote its development to be a clinically utilizable prognostic biomarker.

Source: Cell Proliferation - November 14, 2018 Category: Cytology Authors: Xin Yu, Heyi Zheng, Gary Tse, Lin Zhang, William Ka Kei Wu Tags: REVIEW ARTICLE Source Type: research